| Literature DB >> 30155407 |
Preudtipong Noopetch1, Teerada Ponpinit2, Chusana Suankratay1.
Abstract
Bartonella is among the most common causes of culture-negative infective endocarditis, with B. henselae being one of the most frequently reported species. The clinical presentation of Bartonella endocarditis is similar to that of subacute bacterial endocarditis caused by other bacteria and the diagnosis can be challenging since the organism is difficult to isolate using standard microbiologic culture techniques. In clinical practice, Bartonella endocarditis is usually diagnosed based on serology. To date, only a handful of cases of infective endocarditis caused by Bartonella have been reported in Thailand. Here, we report the case of 51-year-old Thai male with B. henselae endocarditis with dissemination to the lungs, bones, subcutaneous tissue, epididymis, and lymph nodes with a successful outcome.Entities:
Keywords: Bartonella; Bartonella endocarditis; Bartonella henselae; Culture-negative endocarditis; Disseminated Bartonella henselae infection
Year: 2018 PMID: 30155407 PMCID: PMC6111064 DOI: 10.1016/j.idcr.2018.e00441
Source DB: PubMed Journal: IDCases ISSN: 2214-2509
Fig. 1Chest and abdominal computed tomogram. Left (axial view): arrow shows a mass-forming lytic lesion at the left anterior sixth rib and more prominent bilateral pleural effusion at the right side. Right (sagittal view and bone window): image shows multiple lytic lesions in the spine.
Fig. 2Transesophageal echocardiogram showing a vegetation at the aortic valve leaflet (0.9 × 0.5 cm in size).
Fig. 3PCR amplification of pap31 gene. Lane M: 100 bp DNA ladder markers; Lane 1: DNA isolated from patient’s blood sample; Lane 2: positive control bacterial DNA (B. henselae); Lane 3: negative control bacterial DNA (S. pneumoniae).
A summary of seven reported case of Bartonella endocarditis in Southeast Asia.
| Sex and age (years), Province, year reported | Pre-existing disease | Duration of illness | Diagnosis (serology, PCR, culture) | Organ involved apart from IE complications | Treatment: surgery and medication | Outcome, follow-up period |
|---|---|---|---|---|---|---|
| M 57 Y | AS with AR, MS with MR (RHD) | 5 days | PCR of valve, IHC staining of valve and serology | – | AVR and MVR, ampicillin, gentamicin | Improved over 2 months but died suddenly from anticoagulant-associated complications |
| M 53 Y | AR | 9 months | PCR of 16S rRNA gene, sequencing of valve and WSS staining of valve | – | AVR, ceftriaxone, levofloxacin gentamicin, | Improved, follow-up duration unknown |
| M 62 Y | ASD, AR, TR and bioprosthetic pulmonic valve | 5 weeks | Serology, PCR ( | Liver and spleen | AVR, PVR TVR, ceftriaxone, gentamicin, doxycycline | Improved over 9 months |
| M 49 Y | – | 2 months | PCR (16S–23S rRNA intergenic region) and WSS staining of valve | – | AVR, ceftriaxone, gentamicin, doxycycline | Improved over 6 weeks |
| M 51 Y | – | 5 months | PCR ( | Lung, bone, epididymis, lymph nodes | Levofloxacin, azithromycin, doxycycline, gentamicin | Improved over 7 months |
| M 57 Y | – | 1 month | Serology | – | Ceftriaxone, gentamicin | Improved over 12 months |
| F 69 Y | – | 2 months | Serology | – | Ceftriaxone | Improved but died due to gastric perforation |
M: male, F: female, AS: aortic stenosis, AR: aortic regurgitation, MS: mitral stenosis, MR: mitral regurgitation, PS: pulmonic stenosis, TR: tricuspid regurgitation, ASD: atrial septal defect, CHD: congenital heart disease, RHD: rheumatic heart disease, IE: infective endocarditis, AVR: aortic valve replacement, MVR: mitral valve replacement, TVR: tricuspid valve replacement, PVR: pulmonic valve replacement, IHC: immunohistochemical staining, WSS: Warthin–Starry silver.